NCT07094893 2026-01-14
ARIEL-ENGIC
Gruppo Oncologico del Nord-Ovest
Phase 4 Not yet recruiting
Clinical Trials
11 trialsNCT07158164 2025-11-13
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Rutgers, The State University of New Jersey
Phase 4 Recruiting
NCT06090994 2025-05-07
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
Fudan University
Phase 4 Recruiting
NCT01588990 2019-01-22
ASCENT
Hoffmann-La Roche
Phase 4 Completed
NCT00812864 2018-08-28
capagec
University Hospital, Limoges
Phase 4 Completed
NCT03465202 2018-03-14
Association of Capecitabine Pharmacokinetics and Toxicity With Aging
Newcastle-upon-Tyne Hospitals NHS Trust
Phase 4 Unknown
NCT02567331 2016-11-02
A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT02581423 2016-11-02
A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT01641458 2016-02-02
FLOXTOX2
Cantonal Hospital of St. Gallen
Phase 4 Completed
NCT00502671 2015-09-03
A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.
Hoffmann-La Roche
Phase 4 Completed
NCT00216424 2007-11-12
Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma
James A. Haley Veterans Administration Hospital
Phase 4 Terminated